Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - IMMUNE PHARMACEUTICALS INC | v466981_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - IMMUNE PHARMACEUTICALS INC | v466981_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - IMMUNE PHARMACEUTICALS INC | v466981_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - IMMUNE PHARMACEUTICALS INC | v466981_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - IMMUNE PHARMACEUTICALS INC | v466981_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - IMMUNE PHARMACEUTICALS INC | v466981_ex23-1.htm |
Exhibit 21.1
Subsidiaries of Immune Pharmaceuticals Inc.
The following are the subsidiaries of Immune Pharmaceuticals Inc.:
| Name | Jurisdiction of Incorporation |
| Immune Pharmaceuticals USA Corp. | Delaware |
| Immune Pharmaceuticals Ltd. | Israel |
| Maxim Pharmaceuticals, Inc. | Delaware |
| Cytovia, Inc. | Delaware |
| Immune Oncology Pharmaceuticals Inc. | Delaware |
| EpiCept GmbH (closed January 2015) | Germany |